Public Health Agency of Canada

The Public Health Agency of Canada (PHAC) is a federal agency of the Government of Canada, established in 2004 and formalized by legislation in 2006. Its core mission is to protect and improve the health of Canadians, reduce health risks, and prevent diseases and injuries. The agency's headquarters are primarily located in Ottawa, Ontario, with a significant operational presence, including the National Microbiology Laboratory, in Winnipeg, Manitoba.

PHAC's mandate encompasses a wide array of public health services and programs. These include providing public health notices, information on diseases and conditions, guidance for healthy living, and border and travel health advisories. The agency is also responsible for food recalls, risks, and outbreaks, as well as national vaccination and immunization programs. Furthermore, PHAC oversees biosafety and biosecurity measures and leads pandemic preparedness and response efforts. Key initiatives include the National Emergency Stockpile System, the National Antiviral Stockpile, and the Canada Prenatal Nutrition Program.

As of April 2026, Nancy Hamzawi serves as the President of the Public Health Agency of Canada, appointed in June 2025, while Dr. Joss Reimer began her term as the Chief Public Health Officer on April 1, 2026. In a notable recent development, PHAC took over the Vaccine Injury Support Program (VISP) and relaunched it as the Vaccine Impact Assistance Program (VIAP) on April 1, 2026. The agency continues to issue statements on critical public health matters, such as vaccination, reinforcing its role as a cornerstone of Canada's public health framework and a key collaborator with various governmental and international health organizations.

Latest updates

Canadian Health Officials Reiterate Vaccination Support Amidst Evolving Information Landscape

Event summary

  • The Council of Chief Medical Officers of Health (CCMOH) issued a statement on April 27, 2026, reaffirming support for vaccination programs in Canada.
  • The CCMOH highlights the increasing challenge of misinformation and distrust surrounding vaccines, particularly amplified by social media.
  • Canada’s vaccine approval process involves Health Canada review and ongoing monitoring via a global network including the WHO.
  • NACI provides recommendations on vaccination strategies, which are then implemented by provincial and territorial health jurisdictions.

The big picture

This statement underscores the ongoing challenge of maintaining public health confidence in the face of readily available misinformation. The CCMOH's emphasis on trusted sources and transparent processes reflects a strategic shift towards proactive communication and combating the erosion of trust in institutions. The continued reliance on NACI and Health Canada highlights the centralized nature of Canada’s vaccine strategy, which could be a strength or a point of vulnerability depending on future events.

What we're watching

Public Trust
The CCMOH’s statement signals a continued battle against vaccine hesitancy; monitoring public sentiment and trust in health authorities will be critical, especially as new variants emerge.
Regulatory Response
The reliance on Health Canada and NACI suggests a potential vulnerability if either body experiences a loss of credibility or faces political pressure.
Information Ecosystem
The statement’s focus on social media’s role in spreading misinformation indicates that the public health response must increasingly address the evolving digital information landscape.

Canada Shifts Vaccine Injury Support to In-House Administration

Event summary

  • The Government of Canada is transitioning administration of the Vaccine Injury Assistance Program (VIAP) from Oxaro, Inc. effective April 1, 2026.
  • The program provides financial support to Canadians (excluding Quebec) who experienced serious, permanent injuries from Health Canada-authorized vaccines administered since December 8, 2020.
  • The transition aims to address a backlog of applications and improve transparency and consistency in the claims process.
  • Quebec will continue to administer its own Vaccine Injury Compensation Program.

The big picture

This shift represents a strategic move by the Canadian government to internalize a program previously outsourced to a third-party administrator. While the stated goals are improved efficiency and transparency, it also signals a potential reassessment of risk management and liability related to vaccine deployment. The move highlights the ongoing need for robust support systems for individuals experiencing adverse health events following public health interventions, a trend likely to be replicated in other jurisdictions.

What we're watching

Governance Dynamics
Bringing the program in-house suggests a desire for greater control over the process and potentially reduced costs, but could also expose PHAC to increased scrutiny and political pressure.
Regulatory Headwinds
The program’s evolution and future funding will likely be influenced by ongoing public perception of vaccine safety and the broader political climate surrounding vaccine mandates and public health interventions.
Execution Risk
The success of the VIAP hinges on PHAC’s ability to efficiently clear the existing backlog, implement the digital client portal, and maintain consistent, transparent claims processing – a significant operational challenge.

Canada Launches Program to Address Vaccine Impact Fallout

Event summary

  • The Public Health Agency of Canada (PHAC) will host a technical briefing on March 31, 2026, at 3:15 PM EDT.
  • The briefing details the launch of the Vaccine Impact Assistance Program.
  • The briefing is intended for background information only and is not for attribution.
  • Accredited Press Gallery members can participate in the Q&A; others may request temporary access via [email protected].
  • A teleconference line and Zoom webinar are available for listening.

The big picture

The Vaccine Impact Assistance Program signals a proactive approach by the Canadian government to manage the long-term consequences of widespread vaccination campaigns, likely in response to ongoing legal challenges and public concerns. This initiative represents a significant allocation of public resources and could set a precedent for other nations grappling with similar issues. The briefing’s restricted access and non-attribution policy suggest a desire to manage public perception and potentially limit legal exposure.

What we're watching

Liability Exposure
The program's structure and eligibility criteria will reveal the scope of potential vaccine-related liabilities the Canadian government is acknowledging and preparing to address, potentially indicating previously undisclosed risk assessments.
Political Scrutiny
The non-attribution nature of the briefing suggests a desire to control the narrative, implying the program may be politically sensitive and subject to increased scrutiny from opposition parties.
Program Uptake
The ultimate success of the program will depend on its accessibility and perceived fairness, which will dictate the level of participation from affected individuals and the overall financial burden on the government.

Canada Launches Program to Address Vaccine Impact, Details Forthcoming

Event summary

  • The Public Health Agency of Canada (PHAC) will hold a technical briefing on March 31, 2026, at 3:15 PM EDT.
  • The briefing details the launch of the Vaccine Impact Assistance Program.
  • The briefing is intended for background information only and is not for attribution.
  • Accredited Press Gallery members can participate in the Q&A; others can request temporary access via [email protected].
  • Access is available via Zoom webinar and a dial-in teleconference (613-209-3054, Webinar ID: 632 0963 6412, Passcode: 465756).

The big picture

The launch of the Vaccine Impact Assistance Program signals a formal government response to ongoing concerns regarding the societal and economic consequences of widespread vaccination campaigns. This initiative likely reflects a shift towards proactive mitigation of negative impacts, potentially setting a precedent for future public health interventions. The program's design and funding will be closely watched as a test of the government’s commitment to social safety nets in the face of evolving public health challenges.

What we're watching

Program Scope
The program's eligibility criteria and financial support mechanisms will be critical indicators of its intended impact and potential cost to taxpayers. Details on the scope will reveal the government's assessment of the scale of vaccine-related challenges.
Political Risk
The briefing's non-attribution format suggests a sensitivity around the program's details, potentially indicating political pressure or anticipated controversy. The level of scrutiny applied during the briefing will reveal the political stakes involved.
Implementation Speed
The speed at which the program is rolled out and funds are distributed will be a key measure of PHAC's operational efficiency and responsiveness to identified needs. Delays could signal bureaucratic hurdles or resource constraints.

Canada Tightens Biosecurity Oversight Amid Emerging Threat Concerns

Event summary

  • The Government of Canada has received Royal Assent for amendments to the Human Pathogens and Toxins Act (HPTA).
  • The HPTA regulates the handling of human pathogens and toxins across sectors including research, vaccine development, and food quality control.
  • Amendments include provisions for remote access to containment facilities, improved security screening, and reduced reporting thresholds for incidents.
  • The HPTA came into force on December 1, 2015, and supports Canada’s biomanufacturing and global health security agendas.

The big picture

Canada's move to strengthen biosecurity oversight reflects a broader global trend towards heightened vigilance following recent pandemic experiences and increasing concerns about bioweapons proliferation. The amendments aim to balance enabling scientific innovation with mitigating risks, potentially setting a precedent for other nations. This regulatory tightening could impact Canada's competitiveness in the global biomanufacturing landscape, requiring companies to adapt to stricter compliance standards.

What we're watching

Regulatory Headwinds
The increased scrutiny and reporting requirements may create operational burdens for Canadian research institutions and biomanufacturing companies, potentially impacting timelines and costs for new product development.
Governance Dynamics
The shift towards remote access and enhanced security protocols will necessitate significant investment in digital infrastructure and cybersecurity expertise within the regulated sectors.
Incident Response
The reduced reporting threshold suggests a heightened awareness of potential risks; the government's ability to rapidly respond to incidents will be critical in maintaining public trust and minimizing economic disruption.

Canada Invests $600,000 in Culturally Sensitive SRH Services

Event summary

  • The Government of Canada allocated $600,000 to support inclusive sexual and reproductive health (SRH) services.
  • The funding will be distributed to the Association for New Canadians ($210,000) and the Canadian Black, African and Caribbean HIV/AIDS Network ($375,000).
  • The initiative is funded through the SRH Fund, which has provided $87 million to 42 projects since 2021.
  • The announcement was made by Senator Dr. Kristopher Wells on behalf of Minister of Health Marjorie Michel at the Positive Light Gala in Edmonton.

The big picture

This investment signals a continued commitment by the Canadian government to address health inequities among marginalized groups, particularly in the context of rising concerns about access to reproductive healthcare. The allocation of funds to community-based organizations reflects a shift towards decentralized service delivery and culturally tailored approaches. The scale of the SRH Fund ($87 million since 2021) indicates a growing recognition of the systemic barriers faced by these communities.

What we're watching

Implementation Risk
The effectiveness of the program hinges on the ability of the partner organizations to deliver culturally sensitive services and reach the intended underserved populations, which may be difficult to measure.
Political Shifts
Future funding for the SRH Fund may be vulnerable to changes in government priorities or shifts in political ideology, potentially impacting the long-term sustainability of these programs.
Community Response
The success of these initiatives will depend on the engagement and buy-in from the communities they aim to serve, requiring ongoing dialogue and adaptation to ensure relevance and impact.

New CPHO Faces Mounting Public Health Challenges in Canada

Event summary

  • Dr. Joss Reimer has been appointed Chief Public Health Officer (CPHO) of Canada, effective April 1, 2026, for a three-year term.
  • Dr. Reimer succeeds the previous CPHO and brings experience as past President of the Canadian Medical Association and Chief Medical Officer for the Winnipeg Regional Health Authority.
  • The appointment comes as Canada faces a resurgence of vaccine-preventable diseases, avian influenza, HIV, tuberculosis, and the ongoing illegal drug crisis.
  • Dr. Reimer’s prior research focused on sexually transmitted infections and drug-related harms, with projects in Canada and Colombia.

The big picture

The appointment of a new CPHO underscores the ongoing challenges facing Canada's public health system. The confluence of vaccine hesitancy, emerging infectious diseases, and the opioid crisis requires a strong, science-driven leader. Dr. Reimer’s experience in both clinical medicine and public health positions her to address these issues, but the scale of the challenges demands a significant shift in strategy and resource allocation.

What we're watching

Crisis Response
The CPHO's ability to effectively coordinate a response to the concurrent public health threats—measles, avian influenza, drug crisis—will be a key indicator of leadership effectiveness.
Health Communication
Given Dr. Reimer's background in health communication and the prevalence of misinformation, her strategy for countering false health information will be crucial to public health outcomes.
Policy Alignment
How Dr. Reimer navigates the interplay between federal public health guidance and provincial/territorial healthcare systems will determine the overall impact of national health initiatives.

Canada Allocates $4.7M to Dementia Support, Signaling Long-Term Strategy

Event summary

  • The Canadian government announced $4.7 million in funding for six community-based organizations focused on dementia support.
  • The funding is part of the 'A Dementia Strategy for Canada: Together We Aspire' initiative, released in 2019.
  • Since 2015, Canada has invested over $600 million in dementia-related initiatives.
  • Approximately three-in-four Canadians report knowing someone affected by dementia, highlighting the societal impact.

The big picture

This investment underscores Canada's commitment to addressing the growing societal challenge of dementia, a condition exacerbated by an aging population. The $600 million already invested signals a long-term strategic focus, but the effectiveness of these community-based programs will be critical in shaping future policy and resource allocation. The reliance on community organizations suggests a shift towards decentralized care models, which may present both opportunities and challenges in terms of coordination and accountability.

What we're watching

Program Efficacy
The success of these community-based programs will be crucial in demonstrating the value of decentralized dementia support and justifying future funding allocations, particularly given the scale of the broader national strategy.
Strategy Alignment
Continued funding will depend on how effectively these projects align with and contribute to the goals outlined in 'A Dementia Strategy for Canada: Together We Aspire,' especially regarding preventative measures and therapeutic advancements.
Public Perception
Public awareness and acceptance of dementia-focused initiatives, as reflected in the reported prevalence of personal experience, will influence the political viability of ongoing investment and policy changes.

Pillsbury Pizza Pops Recall Exposes Food Safety Vulnerabilities Across Canadian Supply Chain

Event summary

  • A Public Health Agency of Canada investigation has linked 29 cases of E. coli O26 infections across seven Canadian provinces to Pillsbury brand Pizza Pops, with 7 hospitalizations and no reported deaths.
  • The recall affects multiple Pizza Pop varieties and sizes, including Pepperoni + Bacon, Supremo Extreme, and 3 Cheese, distributed between early October 2025 and early January 2026.
  • The investigation is ongoing, and the actual number of affected consumers is likely significantly higher than the confirmed cases due to underreporting.
  • The age range of those infected spans from 1 to 87 years old, with a slight female bias (57%).

The big picture

This outbreak highlights the ongoing vulnerability of food supply chains to contamination events, even within established brands. The incident underscores the importance of robust traceability and preventative measures across the entire food production process. The relatively low number of deaths masks the potential for significant financial and reputational damage to General Mills, Pillsbury’s parent company, and could trigger broader regulatory reviews of frozen food manufacturing standards in Canada.

What we're watching

Supply Chain Resilience
The source of the E. coli contamination remains unknown, raising questions about Pillsbury's supplier oversight and food safety protocols throughout its supply chain, which will likely face increased scrutiny.
Litigation Exposure
Given the number of confirmed cases and potential for unreported illnesses, Pillsbury faces a heightened risk of class-action lawsuits and regulatory penalties, potentially impacting its brand reputation and financial performance.
Consumer Trust
This incident will likely erode consumer trust in frozen food brands, prompting a reassessment of food safety practices and potentially shifting purchasing behavior towards perceived safer alternatives.

Canada to Detail Expansion of 9-8-8 Suicide Crisis Helpline

Event summary

  • Minister of Health Marjorie Michel will deliver an announcement regarding the 9-8-8 Suicide Crisis Helpline on January 16, 2026.
  • The announcement will be followed by a media availability session.
  • The event will be held in Toronto, Ontario, at 10:00 a.m. ET.
  • Media can attend in person or via Zoom (link provided in the release).

The big picture

The expansion of the 9-8-8 Suicide Crisis Helpline represents a significant investment in Canada's mental health infrastructure, mirroring a global trend toward accessible crisis intervention services. This initiative is likely driven by increasing awareness of mental health challenges and a desire to reduce suicide rates, potentially impacting the allocation of healthcare resources and the demand for related services. The success of the program will depend on adequate funding, trained personnel, and effective public outreach.

What we're watching

Resource Allocation
The scope and funding details of the 9-8-8 expansion will reveal the government's commitment to mental health services and the potential strain on existing healthcare infrastructure.
Service Capacity
The ability of crisis centers and support networks to handle increased call volume following the wider rollout of 9-8-8 will be a key indicator of the program's long-term success.
Public Awareness
The effectiveness of public awareness campaigns surrounding the 9-8-8 helpline will influence adoption rates and ultimately impact the program's ability to reduce suicide rates.

Canada to Detail Expansion of 9-8-8 Suicide Crisis Helpline

Event summary

  • Health Minister Marjorie Michel will deliver an announcement regarding the 9-8-8 Suicide Crisis Helpline on January 16, 2026.
  • The announcement will be followed by a media availability session.
  • The event will take place in Toronto, Ontario, at 10:00 a.m. ET.
  • Media can attend in person or via Zoom (link provided in release).

The big picture

The expansion of the 9-8-8 Suicide Crisis Helpline represents a significant investment in Canada's mental health infrastructure, reflecting a growing societal recognition of the need for accessible crisis intervention services. This initiative aligns with a broader global trend toward destigmatizing mental health and providing readily available support systems. The government's approach will be closely scrutinized for its effectiveness in addressing the rising rates of mental health challenges, particularly among vulnerable populations.

What we're watching

Funding Allocation
The scope and specifics of the announcement will reveal the government’s commitment to mental health resources, and the level of funding allocated to support the 9-8-8 helpline’s expansion and ongoing operation.
Service Capacity
The announcement will likely address the capacity of crisis response services to handle increased call volume, and whether sufficient staffing and infrastructure are in place to ensure timely and effective support.
Public Awareness
The success of the 9-8-8 helpline hinges on public awareness and adoption; the announcement will signal the government’s strategy for promoting the service and encouraging its use.
CID: 2055